Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-13 11:38 am Purchase |
2025-06-09 | 13G | UroGen Pharma Ltd. URGN |
Cowen Financial Products LLC | 2,652,500 5.800% |
2,652,500 (New Position) |
Filing History |
| 2025-05-12 5:41 pm Unchanged |
2025-03-31 | 13G | BREEZE HLDGS ACQUISITION CORP BRZH |
Cowen Financial Products LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-05-12 5:37 pm Sale |
2025-03-31 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 891,366 5.000% |
-7,264 (-0.81%) |
Filing History |
| 2025-02-13 12:22 pm Sale |
2024-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cowen Financial Products LLC | 1,909,228 4.900% |
-2,171 (-0.11%) |
Filing History |
| 2024-11-13 5:40 pm Purchase |
2024-09-30 | 13G | Maxeon Solar Technologies, Ltd. MAXN |
Cowen Financial Products LLC | 175,000 0.000% |
147,250 (+530.63%) |
Filing History |
| 2024-11-13 5:36 pm Sale |
2024-09-30 | 13G | LL FLOORING HOLDINGS, INC. LLFLQ |
Cowen Financial Products LLC | 0 0.000% |
-1,622,000 (Position Closed) |
Filing History |
| 2024-11-13 4:40 pm Sale |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
Cowen Financial Products LLC | 0 0.000% |
-5,629,103 (Position Closed) |
Filing History |
| 2024-11-13 3:49 pm Sale |
2024-09-30 | 13G | Adicet Bio, Inc. ACET |
Cowen Financial Products LLC | 0 0.000% |
-2,715,278 (Position Closed) |
Filing History |
| 2024-06-14 09:04 am Purchase |
2024-06-12 | 13G | Maxeon Solar Technologies, Ltd. MAXN |
Cowen Financial Products LLC | 27,750 5.050% |
27,750 (New Position) |
Filing History |
| 2024-05-23 10:47 am Sale |
2024-04-23 | 13G | Canna-Global Acquisition Corp CNGL |
Cowen Financial Products LLC | 195,000 9.890% |
-5,000 (-2.50%) |
Filing History |
| 2024-02-26 10:38 am Purchase |
2023-12-29 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 3,721,659 8.300% |
1,445,553 (+63.51%) |
Filing History |
| 2024-02-26 10:36 am Purchase |
2023-01-04 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 2,276,106 5.770% |
1,028,029 (+82.37%) |
Filing History |
| 2024-02-02 3:17 pm Sale |
2023-12-29 | 13G | DTRT Health Acquisition Corp. DTRTW |
Cowen Financial Products LLC | 0 0.000% |
-224,845 (Position Closed) |
Filing History |
| 2024-02-02 3:16 pm Sale |
2023-12-29 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 898,630 5.270% |
-67,392 (-6.98%) |
Filing History |
| 2024-02-02 12:46 pm Sale |
2023-12-29 | 13G | Vext Science, Inc. VEXTF |
Cowen Financial Products LLC | 0 0.000% |
-4,856,256 (Position Closed) |
Filing History |
| 2024-02-02 12:44 pm Sale |
2023-12-29 | 13G | Verano Holdings Corp. VRNOF |
Cowen Financial Products LLC | 0 0.000% |
-16,497,443 (Position Closed) |
Filing History |
| 2024-02-02 12:43 pm Sale |
2023-12-29 | 13G | Trulieve Cannabis Corp. TCNNF |
Cowen Financial Products LLC | 0 0.000% |
-11,148,292 (Position Closed) |
Filing History |
| 2024-02-02 12:40 pm Purchase |
2023-12-29 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cowen Financial Products LLC | 1,911,399 5.770% |
512,416 (+36.63%) |
Filing History |
| 2024-02-02 12:38 pm Sale |
2023-12-29 | 13G | Sylvamo Corporation SLVM |
Cowen Financial Products LLC | 0 0.000% |
-2,150,000 (Position Closed) |
Filing History |
| 2024-02-02 12:36 pm Sale |
2023-12-29 | 13G | SOL Global Investments Corp. SOLCF |
Cowen Financial Products LLC | 0 0.000% |
-3,434,625 (Position Closed) |
Filing History |